- Home
- GECC vs ME Comparison
GECC vs ME Comparison
Compare GECC & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GECC
- ME
- Stock Information
- Founded
- GECC 2016
- ME 2006
- Country
- GECC United States
- ME United States
- Employees
- GECC N/A
- ME N/A
- Industry
- GECC Finance: Consumer Services
- ME Precision Instruments
- Sector
- GECC Finance
- ME Health Care
- Exchange
- GECC Nasdaq
- ME Nasdaq
- Market Cap
- GECC 106.1M
- ME 113.9M
- IPO Year
- GECC N/A
- ME N/A
- Fundamental
- Price
- GECC $10.34
- ME $3.27
- Analyst Decision
- GECC
- ME Hold
- Analyst Count
- GECC 0
- ME 1
- Target Price
- GECC N/A
- ME $9.40
- AVG Volume (30 Days)
- GECC 28.3K
- ME 321.9K
- Earning Date
- GECC 10-31-2024
- ME 02-05-2025
- Dividend Yield
- GECC 13.47%
- ME N/A
- EPS Growth
- GECC N/A
- ME N/A
- EPS
- GECC 0.65
- ME N/A
- Revenue
- GECC $39,468,000.00
- ME $193,260,000.00
- Revenue This Year
- GECC $18.56
- ME $21.93
- Revenue Next Year
- GECC $5.85
- ME $17.31
- P/E Ratio
- GECC $15.97
- ME N/A
- Revenue Growth
- GECC 16.86
- ME N/A
- 52 Week Low
- GECC $9.55
- ME $2.66
- 52 Week High
- GECC $11.31
- ME $19.34
- Technical
- Relative Strength Index (RSI)
- GECC 57.69
- ME 41.70
- Support Level
- GECC $9.96
- ME $3.03
- Resistance Level
- GECC $10.74
- ME $3.50
- Average True Range (ATR)
- GECC 0.24
- ME 0.33
- MACD
- GECC 0.00
- ME 0.02
- Stochastic Oscillator
- GECC 76.86
- ME 21.05
About GECC Great Elm Capital Corp.
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. The company seeks to generate current income and capital appreciation through debt and equity investments, including investments in specialty finance businesses. It invests in senior secured and senior unsecured debt instruments, as well as in junior loans and mezzanine debt of middle-market companies and small businesses. The company generates revenue from interest on the debt investments that it holds.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.